Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Pacira Pharmaceuticals, Inc. (PCRX)

-NasdaqGS

29.44 Up 0.27(0.93%) May 17, 4:00PM EDT|After Hours : 29.44 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 11,587   10,450   8,486   12,344  
Cost of Revenue11,391  9,672  9,287  6,685  
Gross Profit 196   778   (801) 5,659  
Operating Expenses
Research Development5,905  3,244  3,527  1,872  
Selling General and Administrative12,936  13,363  11,378  10,413  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (18,645) (15,829) (15,706) (6,626)
Income from Continuing Operations
Total Other Income/Expenses Net(3,416)(174)417  (1,176)
Earnings Before Interest And Taxes(22,061)(16,003)(15,289)(7,802)
Interest Expense1,519  343  456  494  
Income Before Tax(23,580)(16,346)(15,745)(8,296)
Income Tax Expense(442) -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(26,536)(16,346)(15,745)(9,358)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (23,138) (16,346) (15,745) (8,296)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (23,138) (16,346) (15,745) (8,296)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.